Ly Vu

The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

Ly Vu, Brian F. Pickering, Yuanming Cheng et al. · Nature Medicine · 2017 · 1.3K citations · Full text

Hematological Malignancy, Chromatin, Myeloid Differentiation +12

Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90

Kamalika Moulick, James H. Ahn, Hongliang Zong et al. · Nature Chemical Biology · 2011 · 258 citations · Full text

Bioinformatics, Engineering, Medicine +7

The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation

Lan Wang, Alexander Gural, Xiao‐Jian Sun et al. · Science · 2011 · 236 citations

Hematological Malignancy, Transcriptional Regulation, Oncogenic Agent +13

m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment

Yuanming Cheng, Hanzhi Luo, Franco Izzo et al. · Cell Reports · 2019 · 163 citations · Full text

Musashi2 sustains the mixed-lineage leukemia–driven stem cell regulatory program

Sun Mi Park, Mithat Gönen, Ly Vu et al. · Journal of Clinical Investigation · 2015 · 109 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Murine Leukemia Model +18